can tirzepatide cause eye issues Focus on GLP-1 drugs & problems One GLP-1 Drug May Be
Description
Wegovy is a weekly injection that contains the active ingredient semaglutide
This is generally fine because it still falls within the weekly dosing window and maintains at least 7 days from your previous dose
Yes, Tirzepatide has been approved by the FDA for weight loss
We prescribe tirzepatide only after a full evaluation and as part of a comprehensive program
